Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Nearly half (49%) havent had their symptoms evaluated, whether because they assume the symptoms are just a normal part of the medication or because they suspect something more is going on but havent pursued it: Only 12% have seen a GI specialist 20% report having searched online or used AI for advice about their symptoms 25% tried over-the-counter remedies such as antacids, fiber supplements, or laxatives on their own 11% turned to social media or health influencers The challenge is compounded by how much the symptoms can vary from person to person
doi: 10.1021/acs.jcim.6b00763 149 HaqM
GLP-1s (Glucagon-Like Peptide-1 receptor agonists) are a class of medications originally developed to help manage type 2 diabetes
the registry records study completion on October 21, 2025
US$ 22.53
US$ 24.15
US$ 26.24
US$ 24.37
US$ 25.95
US$ 22.16
US$ 20.82
